ALT Altimmune Inc

Altimmune Inc is a clinical stage immunotherapeutic biotechnology company. It has two vaccine delivery platforms, RespirVec and Densigen.

$10.50  +0.24 (2.34%)
As of 11/30/2021 15:59:55 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/06/2005
Outstanding shares:  39,738,625
Average volume:  741,624
Market cap:   $414,076,473
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    02155H200
ISIN:        US02155H2004
Sedol:      BFY7DC4
Valuation   (See tab for details)
PE ratio:   -4.86
PB ratio:   1.94
PS ratio:   120.18
Return on equity:   -40.06%
Net income %:   -2,432.90%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy